AutoGel Pad (400-046,400-005)
Top-Rank Health Care Co., Ltd. · Decision date Oct 30, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-30 for K260575, a traditional 510(k) submitted by Top-Rank Health Care Co., Ltd. of Shaoxing, CN, with a receipt date of 02/20/2026. The device is listed as AutoGel Pad (400-046,400-005), classified under 21 CFR 892.1570 as Media, Coupling, Ultrasound, product code MUI, in the Radiology specialty and review panel. SESE means the submission was cleared as substantially equivalent; it is not a PMA approval.
The record shows the submission was not reviewed by a third party, was not a combination product, and had no authorized predetermined change control plan. The listed correspondent is Microkn Medical Technology Service (Shanghai) Co., Ltd. The source does not state which predicate device was used, what materials or gel formulation the pad contains, what the two model numbers distinguish, or what testing supported equivalence; those details would sit in the underlying 510(k) summary rather than this database entry. No clinical performance or labeling claims are recorded here.
The page was last updated 11/16/2026. Nothing in the record describes indications, use instructions or comparative performance, so no clinical reading should be drawn from the clearance alone.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Oct 30, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260575
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Top-Rank Health Care Co., Ltd.
- Product code
- MUI
- Decision code
- SESE
- Decision date
- Oct 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Media, Coupling, Ultrasound.
- Applicant
- Top-Rank Health Care Co., Ltd.
- Product code
- MUI
- FDA device class
- 2
FDA decision timeline
K260575 received
Application receipt date recorded by FDA.
K260575 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MUI
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Foshan Pingchuang Medical Technology Co., Ltd. | 510(k) clearance | Jun 17, 2026 | FDA | |
EdgeFlow Gel PadK252337 | Edgecare, Inc. | 510(k) clearance | Apr 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Top-Rank Health Care Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Shaoxing
Sources and methodology
- Original FDA record: K260575
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
